🇺🇸 FDA
Patent

US 9402830

Methods of treating dyskinesia and related disorders

granted A61KA61K31/198A61K31/4245

Quick answer

US patent 9402830 (Methods of treating dyskinesia and related disorders) held by Melior Discovery, Inc. expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Melior Discovery, Inc.
Grant date
Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/198, A61K31/4245, A61K31/4439, A61K31/501